Mohammad Mujahid

Title: Mohammad Mujahid: Innovator in Pharmaceutical Synthesis

Introduction

Mohammad Mujahid is a notable inventor based in Pune, India. He has made significant contributions to the field of pharmaceutical synthesis, particularly in the development of anti-Parkinson and antiepileptic drugs. With a total of 2 patents to his name, Mujahid's work is recognized for its innovative approaches and high enantiopurity.

Latest Patents

Mujahid's latest patents include an improved process for the synthesis of an anti-Parkinson agent. This invention relates to the synthesis of a compound from commercially available (R)-benzyl glycidyl ether, achieving an enantiopurity greater than 98%. The compound's formula allows for variations in the R group, which can be selected from hydrogen or halogen. Additionally, he has developed a process for the synthesis of the antiepileptic drug Lacosamide. This process is noted for its efficiency and high enantiopurity (greater than 98% ee), starting from commercially available (S)-benzyl glycidyl ether.

Career Highlights

Mujahid is affiliated with the Council of Scientific and Industrial Research, where he continues to advance his research in pharmaceutical chemistry. His work has not only contributed to the scientific community but has also aimed at improving the quality of life for patients suffering from neurological disorders.

Collaborations

Mujahid has collaborated with esteemed colleagues such as Murugan Muthukrishnan and Prashant Pramod Majumdar. These collaborations have further enriched his research and innovation in the field.

Conclusion

In summary, Mohammad Mujahid stands out as an influential inventor in the realm of pharmaceutical synthesis. His innovative processes for drug development reflect his commitment to advancing medical science and improving patient outcomes.